Literature DB >> 14524485

A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer.

G Campbell1, T Pickles, Y D'yachkova.   

Abstract

AIMS: The aim of the study was to assess whether the oral intake of cranberry juice cocktail compared with apple juice was associated with a significant difference in urinary symptoms experienced during radical external beam radiation therapy (EBRT) for prostate carcinoma.
MATERIALS AND METHODS: One hundred and twelve men with prostate cancer were randomised to either 354 ml cranberry juice or apple juice a day. Stratification was based on a history of a previous transurethral resection of prostate (TURP yes/no) and baseline International Prostate Symptom Score (IPSS < 6 or > or = 6) of urinary symptoms.
RESULTS: The maximum IPSS (MRT) and the maximum change in IPSS from baseline (DRT) are used to report the results. We analysed the effects of juice allocation on DRT and MRT using analysis of covariates (ANCOVA). We observed no significant difference for DRT (P = 0.39) or MRT (P = 0.76) related to the consumption of cranberry compared with apple juice. However, we found a significant relationship between the history of a previous TURP and both DRT (P = 0.01) and MRT (P = 0.01). The history of a previous TURP was associated with lower values for both end points. Baseline IPSS was significant for DRT (P = 0.004) and MRT (P < or = 0.001). We found a significant relationship between the baseline IPSS < 6 or > or = 6 cut point on MRT (P < or = 0.001) but not on DRT (P = 0.43). The use of neoadjuvant hormones had no significant effect on DRT (P = 0.64) or MRT (P = 0.76). The use of additional symptomatic medication during the study was not significantly different between the two arms.
CONCLUSIONS: This study shows no significant difference in the urinary symptoms experienced during EBRT related to the consumption of cranberry juice compared with apple juice.

Entities:  

Mesh:

Year:  2003        PMID: 14524485     DOI: 10.1016/s0936-6555(03)00161-4

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  11 in total

Review 1.  A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis.

Authors:  Xavier Liem; Fred Saad; Guila Delouya
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 2.  Chemical hemorrhagic cystitis: Diagnostic and therapeutic pitfalls (Review).

Authors:  Razvan-Cosmin Petca; Razvan-Ionut Popescu; Cristian Toma; Mihai Cristian Dumitrascu; Aida Petca; Florica Sandru; Calin Bogdan Chibelean
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

Review 3.  [Radiation cystitis : Pathophysiology and treatment].

Authors:  S Mühlstädt; N Mohammed; K Weigand; A Schumann; F Kawan; C Göllert; P Fornara
Journal:  Urologe A       Date:  2017-03       Impact factor: 0.639

4.  Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms.

Authors:  Hallie S Rane; Stella M Bernardo; Amy B Howell; Samuel A Lee
Journal:  J Antimicrob Chemother       Date:  2013-10-10       Impact factor: 5.790

5.  Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: a randomized double blinded, placebo controlled pilot study.

Authors:  Katelin Hamilton; Noelle C Bennett; Gordon Purdie; Patries M Herst
Journal:  Support Care Cancer       Date:  2014-07-04       Impact factor: 3.603

6.  Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma.

Authors:  Alberto Bonetta; Francesco Di Pierro
Journal:  Cancer Manag Res       Date:  2012-08-24       Impact factor: 3.989

7.  Preventive effect of Malva on urinary toxicity after radiation therapy in prostate cancer patients: A multi-centric, double-blind, randomized clinical trial.

Authors:  Bahram Mofid; Hossein Rezaeizadeh; Amir Mohammad Jaladat; Fatemeh Atarzadeh; Reihane Moeini; Abbas Motevalian; Ahmad Mosalaie; Farshid Farhan; Afshin Rakhsha; Amir Shahram Yousefi Kashi
Journal:  Electron Physician       Date:  2015-09-16

Review 8.  Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges.

Authors:  Heather Payne; Andrew Adamson; Amit Bahl; Jonathan Borwell; David Dodds; Catherine Heath; Robert Huddart; Rhona McMenemin; Prashant Patel; John L Peters; Andrew Thompson
Journal:  BJU Int       Date:  2013-11       Impact factor: 5.588

Review 9.  Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies.

Authors:  S Faithfull; A Lemanska; P Aslet; N Bhatt; J Coe; L Drudge-Coates; M Feneley; R Glynn-Jones; M Kirby; S Langley; T McNicholas; J Newman; C C Smith; A Sahai; E Trueman; H Payne
Journal:  Int J Clin Pract       Date:  2015-08-20       Impact factor: 2.503

Review 10.  A Narrative Review on the Pathophysiology and Management for Radiation Cystitis.

Authors:  C Browne; N F Davis; E Mac Craith; G M Lennon; D W Mulvin; D M Quinlan; Gerard P Mc Vey; D J Galvin
Journal:  Adv Urol       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.